Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients

Artificial Organs

Volumn 25, Issue 6, 2001, Pages 448-452

  Özdemir, Fatma Nurhan ^a   Güz, Galip ^a   Sezer, Siren ^a   Arat, Zübeyde ^a   Turan, Münire ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Continuous ambulatory peritoneal dialysis; Hemodialysis; Lipids; Lipoprotein

Indexed keywords

BODY FLUIDS; CHOLESTEROL; DISEASES; HEMODIALYZERS; LIPOPROTEINS;

ATHEROSCLEROTIC CHANGES; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HAEMODIALYSIS; HEMODIALYSIS PATIENT; LIPOPROTEIN; LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEINS; PERITONEAL DIALYSIS; RISK FACTORS; TOTAL CHOLESTEROLS;

DIALYSIS;

ALBUMIN; C REACTIVE PROTEIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL;

ADULT; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034822016     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2001.025006448.x     Document Type: Article

References (37)

1. A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis
2. Renal replacement therapy in Canada 1981-1992
3. A six-year comparison of patient and technique survivals in CAPD and hemodialysis
4. A multicentre selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis
5. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital hemodialysis: A multicentric study
6. Lipoprotein [ Lp(a)] and peripheral vascular disease
7. Atherosclerosis in uremia: Possible roles of hyperparathyroidism and intermediate-density lipoprotein accumulation
8. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
9. Cardiovascular risk factors and their management in patients on continuous ambulatory peritoneal dialysis
10. Relation of risk factors for cardiovascular disease to early atherosclerosis detected by ultrasonography in middle aged normotensive hypercholesterolemic men
11. Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients
12. Arterial wall thickness and carotid arteriosclerosis
13. Carotid artery lesions in patients with nondiabetic chronic renal failure
14. Is the determination of LDL cholesterol according to Friedewald accurate in CAPD and HD patients?
15. Triglyceride-rich lipoprotein abnormalities in CAPD-treated patients
16. Is CAPD atherogenic?
17. High-density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
18. Selection-adjusted comparison of life expectancy of patients on continuous ambulatory peritoneal dialysis, hemodialysis and transplantation
19. Cardiovascular factors influencing survival in dialysis patients
20. Outcome in patients on continuous ambulatory peritoneal dialysis and hemodialysis: A 4-year analysis of a prospective multicentre study
21. Ten years of continuous ambulatory peritoneal dialysis: Analysis of patient and technique survival
22. Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. The Framingham Study
23. Is atherogenesis accelerated in hemodialysis patients?
24. Comparison of lipid abnormalities in continuous ambulatory peritoneal dialysis and hemodialysis patients
25. Atherogenic lipids and lipoproteins in hemodialysis patients
26. Lipoprotein (a) in renal disease
27. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levels
28. Multicenter study of lipoprotein (a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis
29. Preliminary evidence for a role of apolipoprotein E alleles in identifying haemodialysis patients at high vascular risk
30. Carotid and femoral intima media thickness (IMT) in the Seychelles heart study 1994: Reproducibility and mean values according to age and sex
31. Fibrinogen: Its emerging role as a cardiovascular risk factor
32. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis
33. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients
34. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
35. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients
36. Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure
37. The effect of cigarette smoking and previous hypertension on the survival of patients treated by continuous ambulatory peritoneal dialysis